Product Information
HYDROXYCHLOROQUINE 200 MG TAB is a generic product labeled by Ipca Laboratories Limited, priced at $0.1485 per EA under NDC 83980000105. Its NADAC has been published 80 times since Feb 12, 2025.
FDA first approved this application on Jun 14, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Ipca Laboratories LimitedNDC
83980000105
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROXYCHLOROQUINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040766FDA Approved
6/14/2007
TE Code
AB
On Market Since
6/3/2024
Pharmacological Classes
Price Statistics
The NADAC for HYDROXYCHLOROQUINE 200 MG TAB has been published 80 times since Feb 12, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1485 per EA |
|---|---|
| All-time high | $0.1657 (Apr 16, 2025) |
| All-time low | $0.1485 (Aug 19, 2026) |
| 52-week high | $0.1643 |
| 52-week low | $0.1485 |
| Median price | $0.1619 |
| Average price | $0.1601 |
| Largest weekly change | +7.1% (Feb 19, 2025) |
| Weeks tracked | 80 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROXYCHLOROQUINE 200 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROXYCHLOROQUINE 200 MG TAB, manufactured by Ipca Laboratories Limited, is $0.1485 per EA (NDC 83980000105), effective Aug 19, 2026.
How has the price of HYDROXYCHLOROQUINE 200 MG TAB changed over time?
Over the history we have for it, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has held within roughly two percent of its current level. It has been tracked across 80 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for HYDROXYCHLOROQUINE 200 MG TAB?
Since Feb 12, 2025, the NADAC for HYDROXYCHLOROQUINE 200 MG TAB has ranged from a low of $0.1485 (Aug 19, 2026) to a high of $0.1657 (Apr 16, 2025), with a median of $0.1619 per EA.
Are there cheaper alternatives to HYDROXYCHLOROQUINE 200 MG TAB?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROXYCHLOROQUINE 200 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROXYCHLOROQUINE 200 MG TAB?
HYDROXYCHLOROQUINE 200 MG TAB (NDC 83980000105) is labeled by Ipca Laboratories Limited, and CMS classifies it as a generic product.